Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: High-grade pancreatic intraepithelial neoplasia and invasive pancreatic ductal adenocarcinoma ≤10 mm are targets for early detection of pancreatic cancer. However, their imaging characteristics are unknown. We aimed to identify endoscopic ultrasound findings for the detection of these lesions. Methods: Patients diagnosed with high-grade pancreatic intraepithelial neoplasia (n=29), pancreatic ductal adenocarcinoma ≤10 mm (n=11) (who underwent surgical resection), or benign main pancreatic duct stenosis (n=20) between January 2014 and January 2021 were retrospectively included. Six features differentiating these lesions were examined by endoscopic ultrasonography: main pancreatic duct stenosis, upstream main pancreatic duct dilation, hypoechoic areas surrounding the main pancreatic duct irregularities (mottled areas without demarcation or round areas with demarcation), branch duct dilation, prominent lobular segmentation, and atrophy. Interobserver agreement was assessed by two independent observers. Results: Hypoechoic areas surrounding the main pancreatic duct irregularities were observed more frequently in high-grade pancreatic intraepithelial neoplasia (82.8%) and pancreatic ductal adenocarcinoma ≤10 mm (90.9%) than in benign stenosis (15.0%) (p<0.001). High-grade pancreatic intraepithelial neoplasia exhibited mottled hypoechoic areas more frequently (79.3% vs 18.9%, p<0.001), and round hypoechoic areas less frequently (3.4% vs 72.7%, p<0.001), than pancreatic ductal adenocarcinoma ≤10 mm. The sensitivity and specificity of hypoechoic areas for differentiating high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma ≤10 mm, and benign stenosis were both 85.0%, with moderate interobserver agreement. Conclusions: The hypoechoic areas surrounding main pancreatic duct irregularities on endoscopic ultrasound may differentiate between high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma ≤10 mm, and benign stenosis (Trial Registration: UMIN Clinical Trials Registry (UMIN000044789).
Abstract
Background/Aims: High-grade pancreatic intraepithelial neoplasia and invasive pancreatic ductal adenocarcinoma ≤10 mm are targets for early detection of pancreatic cancer. However, their imaging characteristics are unknown. We aimed to identify endoscopic ultrasound findings for the detection of these lesions. Methods: Patients diagnosed with high-grade pancreatic intraepithelial neoplasia (n=29), pancreatic ductal adenocarcinoma ≤10 mm (n=11) (who underwent surgical resection), or benign main pancreatic duct stenosis (n=20) between January 2014 and January 2021 were retrospectively included. Six features differentiating these lesions were examined by endoscopic ultrasonography: main pancreatic duct stenosis, upstream main pancreatic duct dilation, hypoechoic areas surrounding the main pancreatic duct irregularities (mottled areas without demarcation or round areas with demarcation), branch duct dilation, prominent lobular segmentation, and atrophy. Interobserver agreement was assessed by two independent observers. Results: Hypoechoic areas surrounding the main pancreatic duct irregularities were observed more frequently in high-grade pancreatic intraepithelial neoplasia (82.8%) and pancreatic ductal adenocarcinoma ≤10 mm (90.9%) than in benign stenosis (15.0%) (p<0.001). High-grade pancreatic intraepithelial neoplasia exhibited mottled hypoechoic areas more frequently (79.3% vs 18.9%, p<0.001), and round hypoechoic areas less frequently (3.4% vs 72.7%, p<0.001), than pancreatic ductal adenocarcinoma ≤10 mm. The sensitivity and specificity of hypoechoic areas for differentiating high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma ≤10 mm, and benign stenosis were both 85.0%, with moderate interobserver agreement. Conclusions: The hypoechoic areas surrounding main pancreatic duct irregularities on endoscopic ultrasound may differentiate between high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma ≤10 mm, and benign stenosis (Trial Registration: UMIN Clinical Trials Registry (UMIN000044789).
참고문헌 (30)
- Siegel RL, "Cancer statistics, 2021", CA Cancer J Clin, 71, pp.7~33 (2021)
- Egawa S, "Japan Pancreatic Cancer Registry; 30th year anniversary : Japan Pancreas Society", Pancreas, 41, pp.985~992 (2012)
- Basturk O, "A revised classification system and reco mmendations from the baltimore consensus meeting for neoplastic precursor lesions in the pancreas", Am J Surg Pathol, 39, pp.1730~1741 (2015)
- Ren B, "Pancreatic ductal adenocarcinoma and its precursor lesions : histopathology, cytopathology, and molecular pathology", Am J Pathol, 189, pp.9~21 (2019)
- Canto MI, "Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance", Gastroenterology, 155, pp.740~751 (2018)
- Lennon AM, "The early detection of pancreatic cancer : what will it take to diagnose and treat curable pancreatic neoplasia?", Cancer Res, 74, pp.3381~3389 (2014)
- Kanno A, "Multicenter study of early pancreatic cancer in Japan", Pancreatology, 18, pp.61~67 (2018)
- Corral JE, "Diagnostic yield from screening asymptomatic individuals at high risk for pancreatic cancer : a meta-analysis of cohort studies", Clin Gastroenterol Hepatol, 17, pp.41~53 (2019)
- Sagami R, "Pre-operative imaging and pathological diagnosis of localized high-grade pancreatic intra-epithelial neoplasia without invasive carcinoma", Cancers(Basel), 13, pp.945~ (2021)
- Nakahodo J, "Focal parenchymal atrophy of pancreas : an important sign of underlying high-grade pancreatic intraepithelial neoplasia without invasive carcinoma, i. e., carcinoma in situ", Pancreatology, 20, pp.1689~1697 (2020)
- Kim SW, "Isolated main pancreatic duct dilatation : CT differentiation between benign and malignant causes", AJR Am J Roentgenol, 209, pp.1046~1055 (2017)
- Kogekar N, "Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI : a meta-analysis", Pancreatology, 20, pp.1739~1746 (2020)
- Kitano M, "Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer", J Gastroenterol, 54, pp.19~32 (2019)
- Landis JR, "The measurement of observer agreement for categorical data", Biometrics, 33, pp.159~174 (1977)
- Henrikson NB, "Screening for pancreatic cancer : updated evidence report and systematic review for the US Preventive Services Task Force", JAMA, 322, pp.445~454 (2019)
- Bartsch DK, "Refinement of screening for familial pancreatic cancer", Gut, 65, pp.1314~1321 (2016)
- Sagami R, "Utility of endoscopic ultrasonography screening for small pancreatic cancer and proposal for a new scoring system for screening", Pancreas, 47, pp.257~264 (2018)
- Goggins M, "Management of patients with increased risk for familial pancreatic cancer : updated reco mmendations from the International Cancer of the Pancreas Screening(CAPS)Consortium", Gut, 69, pp.7~17 (2020)
- Brune K, "Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer", Am J Surg Pathol, 30, pp.1067~1076 (2006)
- Klöppel G, "Fibrosis of the pancreas : the initial tissue damage and the resulting pattern", Virchows Arch, 445, pp.1~8 (2004)
- Detlefsen S, "Pancreatic fibrosis associated with age and ductal papillary hyperplasia", Virchows Arch, 447, pp.800~805 (2005)
- Meckler KA, "Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma", Am J Surg Pathol, 25, pp.1047~1053 (2001)
- Izumi Y, "Endoscopic ultrasound findings and pathological features of pancreatic carcinoma in situ", Endosc Int Open, 7, pp.E585~E593 (2019)
- Canto MI, "Frequent detection of pancreatic lesions in asymptomatic high-risk individuals", Gastroenterology, 142, pp.796~804 (2012)
- Matsuda Y, "Age-related morphological changes in the pancreas and their association with pancreatic carcinogenesis", Pathol Int, 69, pp.450~462 (2019)
- Kim JH, "Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT : frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations", Radiology, 257, pp.87~96 (2010)
- Yamao K, "Partial pancreatic parenchymal atrophy is a new specific finding to diagnose small pancreatic cancer(≤10 mm)including carcinoma in situ : comparison with localized benign main pancreatic duct stenosis patients", Diagnostics(Basel), 10, pp.445~ (2020)
- Bartsch DK, "Multiple small"imaging"branch-duct type intraductal papillary mucinous neoplasms(IPMNs)in familial pancreatic cancer : indicator for concomitant high grade pancreatic intraepithelial neoplasia?", Fam Cancer, 12, pp.89~96 (2013)
- Topazian M, "Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds", Gastrointest Endosc, 66, pp.62~67 (2007)
- Yachida S, "Distant metastasis occurs late during the genetic evolution of pancreatic cancer", Nature, 467, pp.1114~1117 (2010)